Furthermore, we show that genetic deletion of α6 in (myo)fibroblasts or pharmacological blockade of the c-Fos/c-Jun mechanotransduction pathway, which regulates α6-expression, protects mice against experimental lung fibrosis. The gene discussed is FOS; the disease is pulmonary fibrosis.